![Christopher Mason](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Mason
Directeur/Membre du Conseil chez
KRYSTAL BIOTECH, INC.
Fortune : - $ au 31/05/2026
Profil
Christopher Mason was the founder of Stem Cell Translation Ltd. (2006) serving as Director until 2018, London Regenerative Medicine Network Ltd. (2008) serving as Director since 2008, Oribiotech Ltd. (2015) serving as Non-Executive Director, AVROBIO, Inc. (2015) serving as Chief Scientific Officer from 2015 to 2022, and Sun Vectors, Inc. (2022) serving as Chief Executive Officer & Director since 2022.
Current jobs include Director at Alliance for Regenerative Medicine since 2021, Independent Director at Krystal Biotech, Inc. since 2021, and Professor at University College London since 1999.
Former jobs include Trustee at UK Stem Cell Foundation from 2010 to 2016 and Trustee at The British Neurological Research Trust from 2012 to 2016.
Education includes undergraduate degree from Imperial College London, doctorate degrees from University College London and King's College London.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 23/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Christopher Mason
| Sociétés | Poste | Début |
|---|---|---|
| KRYSTAL BIOTECH, INC. | Directeur/Membre du Conseil | 04/01/2021 |
London Regenerative Medicine Network Ltd. | Fondateur | 01/02/2008 |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Directeur/Membre du Conseil | 01/10/2021 |
Anciens postes connus de Christopher Mason
| Sociétés | Poste | Fin |
|---|---|---|
| TECTONIC THERAPEUTIC, INC. | Fondateur | 30/06/2022 |
Stem Cell Translation Ltd. | Fondateur | 01/03/2018 |
The British Neurological Research Trust | Directeur/Membre du Conseil | 01/05/2016 |
UK Stem Cell Foundation
 UK Stem Cell Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Directeur/Membre du Conseil | 01/05/2016 |
Oribiotech Ltd.
 Oribiotech Ltd. BiotechnologyHealth Technology Develops and manufactures cell and gene therapy | Fondateur | - |
Formation de Christopher Mason
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College London
University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UK Stem Cell Foundation
UK Stem Cell Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
King's College London
 King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
The British Neurological Research Trust | |
AVROBIO, Inc.
 AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose | Health Technology |
Krystal Biotech, Inc.
 Krystal Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops gene therapies to patients living with debilitating diseases | Health Technology |
Oribiotech Ltd.
Oribiotech Ltd. BiotechnologyHealth Technology Develops and manufactures cell and gene therapy | Health Technology |
London Regenerative Medicine Network Ltd. | |
Stem Cell Translation Ltd. |
